Pfizer funnels $1B into protein degrader Arvinas, with more in biobucks on the table

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 22, 2021 at 11:52 AM.

  1. #1 cafead, Jul 22, 2021 at 11:52 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via Pfizer is doubling down on Arvinas. Three years after the duo inked a discovery and development deal, they’re adding commercialization to the mix. Pfizer is forking over $650 million upfront and investing $350 million in Arvinas to develop and commercialize the latter’s protein-degrading breast cancer drug.

    article source
     
    Quote

Reply to Thread